Finance

Beta
Lists
2929:TYO
Pharma Foods International Co., Ltd.
Â¥533.00
-1.66%
(-9.00) 1D
Jun 12, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 2929...
Open
Â¥544
High
Â¥558
Low
Â¥532
Mkt. cap
15.50B
Avg. vol.
174.10K
Volume
241.90K
Dividend
4.69%
Quarterly dividend
Â¥6
Ex-dividend date
Jul 30, 2026
52-wk high
Â¥1,064
52-wk low
Â¥527
EPS
-Â¥58
Shares outstanding
29.03M
No. of employees
613
Open
Â¥544
High
Â¥558
Low
Â¥532
Mkt. cap
15.50B
Avg. vol.
174.10K
Volume
241.90K
Dividend
4.69%
Quarterly dividend
Â¥6
Ex-dividend date
Jul 30, 2026
52-wk high
Â¥1,064
52-wk low
Â¥527
EPS
-Â¥58
Shares outstanding
29.03M
No. of employees
613
News stories
From sources across the web
About Pharma Foods International Co., Ltd.
CEO-
Employees613
FoundedSep 12, 1997
Headquarters-
SectorBiotechnology
Websitepharmafoods.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
18.44B
15.71B
16.73B
16.11B
Cost of goods sold
3.59B
3.08B
3.06B
3.21B
Cost of revenue
3.59B
3.08B
3.06B
3.21B
Research and development expenses
439.00M
332.00M
359.00M
425.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.82B
14.80B
13.15B
11.54B
Operating expense
12.27B
15.14B
13.52B
11.97B
Total operating expenses
15.86B
18.22B
16.58B
15.18B
Operating income
2.58B
-2.51B
149.00M
931.00M
Other non operating income
208.00M
-131.00M
73.00M
30.00M
EBT including unusual items
2.66B
-2.64B
90.00M
893.00M
EBT excluding unusual items
2.78B
-2.65B
212.00M
893.00M
Income tax expense
1.17B
-749.00M
23.00M
130.00M
Effective tax rate
44.05%
28.37%
25.56%
14.56%
Other operating expenses
-
-
-
-
Net income
1.49B
-1.89B
67.00M
763.00M
Net profit margin
8.08%
-12.04%
0.40%
4.74%
Earnings per share
-
-
-
-
Interest and investment income
18.00M
10.00M
17.00M
8.00M
Interest expense
-23.00M
-25.00M
-34.00M
-49.00M
Net interest expenses
-5.00M
-15.00M
-17.00M
-41.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.80B
-2.34B
327.00M
1.12B
Gain or loss from assets sale
-
-4.00M
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer